Cancer patients in Michigan don’t have enough access to potentially lifesaving treatment.
Chimeric antigen receptor T cell (CAR T) therapy is an innovative cancer treatment, currently involved in hundreds of clinical trials across the country. But while it’s bringing many cancer patients hope, bureaucratic barriers are keeping the treatment from many Michiganders.
The State Certificate of Need Commission, which is made up of unelected members, has placed CON restrictions on CAR T. Before a health care facility can offer the treatment, it must first get approval from the commission, as well as third-party accreditation. This goes beyond what is required by the Food and Drug Administration.
Overburdensome restrictions cost significant amounts of time and money. So, while a handful of health care facilities may have the resources, most do not.
Send your representative a letter today, urging them to end these CON restrictions and bring hope to patients across Michigan.